Musculoskeletal Education and Research Center, Department of Orthopaedic Surgery, Institute for Orthopaedics and Neurosciences, Carilion Clinic, VA.
Virginia Tech Carilion, Department of Surgery, Plastic Surgery Section, VA.
J Hand Surg Am. 2023 May;48(5):460-467. doi: 10.1016/j.jhsa.2023.01.014. Epub 2023 Mar 15.
Digital amputation is a commonly performed procedure for infection and necrosis in patients with diabetes, peripheral vascular disease (PVD), and on dialysis. There is a lack of data regarding prognosis for revision amputation and mortality following digital amputation in these patients.
All digital amputations over 10-year period (2008-2018) at a single center were reviewed. There were 484 amputations in 360 patients, among which 358 were performed for trauma (reference sample) and 126 for infection or necrosis (sample of interest). Patient death and revision were determined from National Vital Statistics System and medical records. Propensity score matching was performed to compare groups. Data were then compared to the Social Security Administration Actuarial Life Table for 2015 to determine age-matched expected mortality.
The 2-year revision rate was 34% for amputations performed for infection or necrosis, compared to 15% for amputations due to trauma. For amputations performed for infection or necrosis, the revision rate was 47.7% when diabetes, PVD, and dialysis were present. Among all patients with infection or necrosis (n = 104) undergoing a digital amputation, overall survival at 2, 5, and 10 years was 79.4%, 57.3%, and 17.5%, respectively, which represented a 3.2-fold increased risk of death compared to controls. (hazard ratio, 3.19; 95% confidence interval, 1.47-6.93). For amputations due to trauma, mortality was no different from that in the age-matched general population.
Mortality and revision risk are high for patients requiring a digital amputation for infection or necrosis and are further increased with medical comorbidities. Hand surgeons should consider the prognostic implications of these data when counseling patients.
TYPE OF STUDY/LEVEL OF EVIDENCE: Prognostic IV.
对于患有糖尿病、外周血管疾病(PVD)和透析的患者,数字截肢是一种常见的用于感染和坏死的手术。对于这些患者的数字截肢后的翻修截肢和死亡率的预后数据,目前还很缺乏。
回顾了单一中心在 10 年内(2008 年至 2018 年)进行的所有数字截肢手术。在 360 名患者中,有 484 例截肢手术,其中 358 例是因创伤(参考样本)进行的,126 例是因感染或坏死(感兴趣的样本)进行的。患者的死亡和翻修是通过国家生命统计系统和病历确定的。采用倾向评分匹配法对两组进行比较。然后,将数据与 2015 年社会安全管理局寿命表进行比较,以确定年龄匹配的预期死亡率。
因感染或坏死而进行的截肢手术的 2 年翻修率为 34%,而因创伤而进行的截肢手术的翻修率为 15%。对于因感染或坏死而进行的截肢手术,如果同时存在糖尿病、PVD 和透析,翻修率为 47.7%。在所有因感染或坏死(n=104)而接受数字截肢的患者中,2 年、5 年和 10 年的总生存率分别为 79.4%、57.3%和 17.5%,与对照组相比,死亡风险增加了 3.2 倍(风险比,3.19;95%置信区间,1.47-6.93)。对于因创伤而进行的截肢手术,其死亡率与年龄匹配的一般人群没有差异。
对于因感染或坏死而需要进行数字截肢的患者,其死亡率和翻修风险都很高,而且随着医疗合并症的增加,风险进一步增加。手部外科医生在为患者提供咨询时,应考虑这些数据的预后意义。
研究类型/证据水平:预后 IV 级。